APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Smoking Cessation Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Smoking Cessation Drugs Industry Growth and Trends Forecast to 2032

Report ID 174036300120 December 2025101 pages

Choose your research edition.

Industry ResearchSmoking Cessation Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Smoking Cessation Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Smoking Cessation Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Smoking Cessation Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Smoking Cessation Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Smoking Cessation Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Smoking Cessation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Smoking Cessation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Smoking Cessation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Smoking Cessation Drugs include GSK, Dr. Reddy's Laboratories, Fontem Ventures, Kimree Technology, Perrigo Company, Smoke Away, The Harvard Drug Group, Pfizer and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Smoking Cessation Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Smoking Cessation Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Smoking Cessation Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Smoking Cessation Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Smoking Cessation Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Smoking Cessation Drugs Market by Company

GSK

Dr. Reddy's Laboratories

Fontem Ventures

Kimree Technology

Perrigo Company

Smoke Away

The Harvard Drug Group

Pfizer

Novartis

Johnson & Johnson

Smoking Cessation Drugs Segment by Type

NRTs Products

Nicotine-Free Products

Smoking Cessation Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Others

Smoking Cessation Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smoking Cessation Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Smoking Cessation Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smoking Cessation Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Smoking Cessation Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Smoking Cessation Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of NRTs Products Table 2. Major Company of Nicotine-Free Products Table 3. Global Smoking Cessation Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 5. Global Smoking Cessation Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Smoking Cessation Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Smoking Cessation Drugs Price by Type (2021-2026) & (US$/Ton) Table 9. Global Smoking Cessation Drugs Sales by Type (2027-2032) & (W Tons) Table 10. Global Smoking Cessation Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Smoking Cessation Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Smoking Cessation Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Smoking Cessation Drugs Price by Type (2027-2032) & (US$/Ton) Table 14. North America Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 15. North America Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 17. Europe Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 19. Asia-Pacific Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 21. Latin America Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Smoking Cessation Drugs Sales by Type (2021-2026) & (W Tons) Table 23. Middle East and Africa Smoking Cessation Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Smoking Cessation Drugs Industry Trends Table 25. Smoking Cessation Drugs Industry Drivers Table 26. Smoking Cessation Drugs Industry Opportunities and Challenges Table 27. Smoking Cessation Drugs Industry Restraints Table 28. Global Smoking Cessation Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Smoking Cessation Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Smoking Cessation Drugs Sales by Company (2021-2026) & (W Tons) Table 31. Global Smoking Cessation Drugs Sales Share by Company (2021-2026) Table 32. Global Smoking Cessation Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Smoking Cessation Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Smoking Cessation Drugs Major Company Production Sites and Headquarters Table 35. Global Smoking Cessation Drugs Company, Product Type & Application Table 36. Global Smoking Cessation Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Smoking Cessation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Smoking Cessation Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Smoking Cessation Drugs Sales by Region (2021-2026) & (W Tons) Table 41. Global Smoking Cessation Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Smoking Cessation Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Smoking Cessation Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Smoking Cessation Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Smoking Cessation Drugs Sales by Region (2027-2032) & (W Tons) Table 46. Global Smoking Cessation Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Smoking Cessation Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Smoking Cessation Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Smoking Cessation Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Smoking Cessation Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 52. Global Smoking Cessation Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Smoking Cessation Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Smoking Cessation Drugs Price by Application (2021-2026) & (US$/Ton) Table 56. Global Smoking Cessation Drugs Sales by Application (2027-2032) & (W Tons) Table 57. Global Smoking Cessation Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Smoking Cessation Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Smoking Cessation Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Smoking Cessation Drugs Price by Application (2027-2032) & (US$/Ton) Table 61. North America Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 62. North America Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 64. Europe Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 66. Asia-Pacific Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 68. Latin America Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Smoking Cessation Drugs Sales by Application (2021-2026) & (W Tons) Table 70. Middle East and Africa Smoking Cessation Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. GSK Smoking Cessation Drugs Product Portfolio Table 75. GSK Recent Development Table 76. Dr. Reddy's Laboratories Company Information Table 77. Dr. Reddy's Laboratories Business Overview Table 78. Dr. Reddy's Laboratories Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Dr. Reddy's Laboratories Smoking Cessation Drugs Product Portfolio Table 80. Dr. Reddy's Laboratories Recent Development Table 81. Fontem Ventures Company Information Table 82. Fontem Ventures Business Overview Table 83. Fontem Ventures Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Fontem Ventures Smoking Cessation Drugs Product Portfolio Table 85. Fontem Ventures Recent Development Table 86. Kimree Technology Company Information Table 87. Kimree Technology Business Overview Table 88. Kimree Technology Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Kimree Technology Smoking Cessation Drugs Product Portfolio Table 90. Kimree Technology Recent Development Table 91. Perrigo Company Company Information Table 92. Perrigo Company Business Overview Table 93. Perrigo Company Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Perrigo Company Smoking Cessation Drugs Product Portfolio Table 95. Perrigo Company Recent Development Table 96. Smoke Away Company Information Table 97. Smoke Away Business Overview Table 98. Smoke Away Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Smoke Away Smoking Cessation Drugs Product Portfolio Table 100. Smoke Away Recent Development Table 101. The Harvard Drug Group Company Information Table 102. The Harvard Drug Group Business Overview Table 103. The Harvard Drug Group Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. The Harvard Drug Group Smoking Cessation Drugs Product Portfolio Table 105. The Harvard Drug Group Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Pfizer Smoking Cessation Drugs Product Portfolio Table 110. Pfizer Recent Development Table 111. Novartis Company Information Table 112. Novartis Business Overview Table 113. Novartis Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Novartis Smoking Cessation Drugs Product Portfolio Table 115. Novartis Recent Development Table 116. Johnson & Johnson Company Information Table 117. Johnson & Johnson Business Overview Table 118. Johnson & Johnson Smoking Cessation Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Johnson & Johnson Smoking Cessation Drugs Product Portfolio Table 120. Johnson & Johnson Recent Development Table 121. North America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 122. North America Smoking Cessation Drugs Sales by Country (2021-2026) & (W Tons) Table 123. North America Smoking Cessation Drugs Sales Market Share by Country (2021-2026) Table 124. North America Smoking Cessation Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 125. North America Smoking Cessation Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Smoking Cessation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Smoking Cessation Drugs Market Share by Country (2021-2026) Table 129. North America Smoking Cessation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Smoking Cessation Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 132. Europe Smoking Cessation Drugs Sales by Country (2021-2026) & (W Tons) Table 133. Europe Smoking Cessation Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Smoking Cessation Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 135. Europe Smoking Cessation Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Smoking Cessation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Smoking Cessation Drugs Market Share by Country (2021-2026) Table 139. Europe Smoking Cessation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Smoking Cessation Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Smoking Cessation Drugs Sales by Country (2021-2026) & (W Tons) Table 143. Asia-Pacific Smoking Cessation Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Smoking Cessation Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 145. Asia-Pacific Smoking Cessation Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Smoking Cessation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Smoking Cessation Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Smoking Cessation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Smoking Cessation Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 152. Latin America Smoking Cessation Drugs Sales by Country (2021-2026) & (W Tons) Table 153. Latin America Smoking Cessation Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Smoking Cessation Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 155. Latin America Smoking Cessation Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Smoking Cessation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Smoking Cessation Drugs Market Share by Country (2021-2026) Table 159. Latin America Smoking Cessation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Smoking Cessation Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Smoking Cessation Drugs Sales by Country (2021-2026) & (W Tons) Table 163. Middle East and Africa Smoking Cessation Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Smoking Cessation Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 165. Middle East and Africa Smoking Cessation Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Smoking Cessation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Smoking Cessation Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Smoking Cessation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Smoking Cessation Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Smoking Cessation Drugs Distributors List Table 174. Smoking Cessation Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Smoking Cessation Drugs Image Figure 2. Global Smoking Cessation Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Smoking Cessation Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Smoking Cessation Drugs Sales (2021-2032) & (W Tons) Figure 5. NRTs Products Image Figure 6. Global NRTs Products Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Nicotine-Free Products Image Figure 8. Global Nicotine-Free Products Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Global Smoking Cessation Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Smoking Cessation Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Smoking Cessation Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Smoking Cessation Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Smoking Cessation Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Smoking Cessation Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Smoking Cessation Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Smoking Cessation Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Smoking Cessation Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Smoking Cessation Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Smoking Cessation Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Smoking Cessation Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Smoking Cessation Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (W Tons) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Global Smoking Cessation Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Smoking Cessation Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Smoking Cessation Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Smoking Cessation Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Smoking Cessation Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Smoking Cessation Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Smoking Cessation Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Smoking Cessation Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Smoking Cessation Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Smoking Cessation Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Smoking Cessation Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Smoking Cessation Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Smoking Cessation Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 44. North America Smoking Cessation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Smoking Cessation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Smoking Cessation Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. Europe Smoking Cessation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Smoking Cessation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Smoking Cessation Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Asia-Pacific Smoking Cessation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Smoking Cessation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Smoking Cessation Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Latin America Smoking Cessation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Smoking Cessation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Smoking Cessation Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Middle East and Africa Smoking Cessation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Smoking Cessation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Smoking Cessation Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Smoking Cessation Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • NRTs Products
  • Nicotine-Free Products
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • GSK
  • Dr. Reddy's Laboratories
  • Fontem Ventures
  • Kimree Technology
  • Perrigo Company
  • Smoke Away
  • The Harvard Drug Group
  • Pfizer
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Smoking Cessation Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Smoking Cessation Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Smoking Cessation Drugs Market by Type
  6. 1.3.1 NRTs Products
  7. 1.3.2 Nicotine-Free Products
  8. 1.4 Global Smoking Cessation Drugs Market Size by Type
  9. 1.4.1 Global Smoking Cessation Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Smoking Cessation Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Smoking Cessation Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Smoking Cessation Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Smoking Cessation Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Smoking Cessation Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Smoking Cessation Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Smoking Cessation Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Smoking Cessation Drugs Industry Trends
  2. 2.2 Smoking Cessation Drugs Industry Drivers
  3. 2.3 Smoking Cessation Drugs Industry Opportunities and Challenges
  4. 2.4 Smoking Cessation Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Smoking Cessation Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Smoking Cessation Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Smoking Cessation Drugs Price (2021-2026)
  4. 3.4 Global Smoking Cessation Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Smoking Cessation Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Smoking Cessation Drugs Company, Product Type & Application
  7. 3.7 Global Smoking Cessation Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Smoking Cessation Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Smoking Cessation Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Smoking Cessation Drugs Tier 1, Tier 2, and Tier 3
4 Smoking Cessation Drugs Regional Status and Outlook
  1. 4.1 Global Smoking Cessation Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Smoking Cessation Drugs Historic Market Size by Region
  3. 4.2.1 Global Smoking Cessation Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Smoking Cessation Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Smoking Cessation Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Smoking Cessation Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Smoking Cessation Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Smoking Cessation Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Smoking Cessation Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Smoking Cessation Drugs by Application
  1. 5.1 Smoking Cessation Drugs Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Smoking Cessation Drugs Market Size by Application
  7. 5.2.1 Global Smoking Cessation Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Smoking Cessation Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Smoking Cessation Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Smoking Cessation Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Smoking Cessation Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Smoking Cessation Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Smoking Cessation Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Smoking Cessation Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Smoking Cessation Drugs Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Smoking Cessation Drugs Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 Fontem Ventures
  14. 6.3.1 Fontem Ventures Company Information
  15. 6.3.2 Fontem Ventures Business Overview
  16. 6.3.3 Fontem Ventures Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fontem Ventures Smoking Cessation Drugs Product Portfolio
  18. 6.3.5 Fontem Ventures Recent Developments
  19. 6.4 Kimree Technology
  20. 6.4.1 Kimree Technology Company Information
  21. 6.4.2 Kimree Technology Business Overview
  22. 6.4.3 Kimree Technology Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kimree Technology Smoking Cessation Drugs Product Portfolio
  24. 6.4.5 Kimree Technology Recent Developments
  25. 6.5 Perrigo Company
  26. 6.5.1 Perrigo Company Company Information
  27. 6.5.2 Perrigo Company Business Overview
  28. 6.5.3 Perrigo Company Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Perrigo Company Smoking Cessation Drugs Product Portfolio
  30. 6.5.5 Perrigo Company Recent Developments
  31. 6.6 Smoke Away
  32. 6.6.1 Smoke Away Company Information
  33. 6.6.2 Smoke Away Business Overview
  34. 6.6.3 Smoke Away Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Smoke Away Smoking Cessation Drugs Product Portfolio
  36. 6.6.5 Smoke Away Recent Developments
  37. 6.7 The Harvard Drug Group
  38. 6.7.1 The Harvard Drug Group Company Information
  39. 6.7.2 The Harvard Drug Group Business Overview
  40. 6.7.3 The Harvard Drug Group Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 The Harvard Drug Group Smoking Cessation Drugs Product Portfolio
  42. 6.7.5 The Harvard Drug Group Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Smoking Cessation Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Smoking Cessation Drugs Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Johnson & Johnson
  56. 6.10.1 Johnson & Johnson Company Information
  57. 6.10.2 Johnson & Johnson Business Overview
  58. 6.10.3 Johnson & Johnson Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Johnson & Johnson Smoking Cessation Drugs Product Portfolio
  60. 6.10.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Smoking Cessation Drugs Sales by Country
  2. 7.1.1 North America Smoking Cessation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Smoking Cessation Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Smoking Cessation Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Smoking Cessation Drugs Market Size by Country
  6. 7.2.1 North America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Smoking Cessation Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Smoking Cessation Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Smoking Cessation Drugs Sales by Country
  2. 8.1.1 Europe Smoking Cessation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Smoking Cessation Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Smoking Cessation Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Smoking Cessation Drugs Market Size by Country
  6. 8.2.1 Europe Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Smoking Cessation Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Smoking Cessation Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Smoking Cessation Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Smoking Cessation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Smoking Cessation Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Smoking Cessation Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Smoking Cessation Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Smoking Cessation Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Smoking Cessation Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Smoking Cessation Drugs Sales by Country
  2. 10.1.1 South America Smoking Cessation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Smoking Cessation Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Smoking Cessation Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Smoking Cessation Drugs Market Size by Country
  6. 10.2.1 South America Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Smoking Cessation Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Smoking Cessation Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Smoking Cessation Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Smoking Cessation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Smoking Cessation Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Smoking Cessation Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Smoking Cessation Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Smoking Cessation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Smoking Cessation Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Smoking Cessation Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Smoking Cessation Drugs Value Chain Analysis
  2. 12.1.1 Smoking Cessation Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Smoking Cessation Drugs Production Mode & Process
  7. 12.2 Smoking Cessation Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Smoking Cessation Drugs Distributors
  10. 12.2.3 Smoking Cessation Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst